KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Operating Leases (2019 - 2026)

Neogenomics filings provide 8 years of Operating Leases readings, the most recent being $61.5 million for Q1 2026.

  • On a quarterly basis, Operating Leases rose 2.67% to $61.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $61.5 million, a 2.67% increase, with the full-year FY2025 number at $62.8 million, up 3.26% from a year prior.
  • Operating Leases hit $61.5 million in Q1 2026 for Neogenomics, down from $62.8 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $73.4 million in Q1 2022 to a low of $59.9 million in Q1 2025.
  • Median Operating Leases over the past 5 years was $64.8 million (2024), compared with a mean of $65.5 million.
  • Biggest five-year swings in Operating Leases: skyrocketed 44.85% in 2022 and later fell 12.01% in 2023.
  • Neogenomics' Operating Leases stood at $69.0 million in 2022, then fell by 1.57% to $67.9 million in 2023, then dropped by 10.36% to $60.8 million in 2024, then grew by 3.26% to $62.8 million in 2025, then fell by 2.17% to $61.5 million in 2026.
  • The last three reported values for Operating Leases were $61.5 million (Q1 2026), $62.8 million (Q4 2025), and $64.3 million (Q3 2025) per Business Quant data.